Back
Veeva Systems 10K Form
Sell
33
VEEV
Veeva Systems
Last Price:
204.02
Seasonality Move:
-4.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-09-08 | 10Q | VEEV/Veeva Systems Quarterly |
2020-06-04 | 10Q | VEEV/Veeva Systems Quarterly |
2020-03-30 | 10K | VEEV/Veeva Systems Annual |
2019-12-05 | 10Q | VEEV/Veeva Systems Quarterly |
2019-09-05 | 10Q | VEEV/Veeva Systems Quarterly |
2019-06-06 | 10Q | VEEV/Veeva Systems Quarterly |
Receive VEEV News And Ratings
See the #1 stock for the next 7 days that we like better than VEEV
VEEV Financial Statistics
Sales & Book Value
Annual Sales: | $2.16B |
---|---|
Cash Flow: | $265.04M |
Price / Cash Flow: | 34.91 |
Annual Sales: | $25.85 |
Price / Book: | 8.1 |
Profitability
EPS (TTM): | 3.32000 |
---|---|
Net Income (TTM): | $540.14M |
Gross Margin: | $1.55B |
Return on Equity: | 14.62% |
Return on Assets: | 11.56% |
Veeva Systems Earnings Forecast
Key Veeva Systems Financial Ratios
- The Gross Profit Margin over the past 13 years for VEEV is 71.72%.
- The Selling, General & Administrative Expenses for VEEV have been equal to 26.28% of Gross Profit Margin.
- The Research & Development expenses have been 24.14% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of VEEV is 22.63% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 11 years.
Veeva Systems Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Information Services |
Sector: | Healthcare |
Current Symbol: | VEEV |
CUSIP: | 922475 |
Website: | veeva.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 4.35 |
Quick Ratio: | 4.28 |
Price-to-Earnings
Trailing P/E Ratio: | 69.83 |
---|---|
Forward P/E Ratio: | 44.8 |
VEEV Technical Analysis vs Fundamental Analysis
Sell
33
Veeva Systems (VEEV)
is a Sell
Is Veeva Systems a Buy or a Sell?
-
Veeva Systems stock is rated a Sell
The current Veeva Systems [VEEV] share price is $209.49. The Score for VEEV is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.